FSD Pharma Inc. (HUGE)

FSD Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	6	36	30	41	20	-
Market Cap Growth	-52.81%	20.48%	-27.10%	108.43%	-	-
Enterprise Value	-0	28	18	14	6	-3
PE Ratio	-	-2.69	-1.74	-1.49	-0.79	-
PB Ratio	0.64	3.64	1.35	0.98	0.69	-
P/FCF Ratio	-4.76	-4.45	-1.43	-2.48	-1.32	-
P/OCF Ratio	-4.76	-4.45	-1.45	-2.54	-1.32	-
EV/EBITDA Ratio	-3.62	-2.45	-1.30	-0.57	-0.30	0.12
EV/EBIT Ratio	-3.07	-2.11	-1.05	-0.51	-0.26	0.11
EV/FCF Ratio	-3.75	-3.49	-0.86	-0.84	-0.43	0.31
Debt / Equity Ratio	0.05	0.03	0.02	0.01	0.01	0.04
Debt / EBITDA Ratio	-0.07	-0.02	-0.03	-0.02	-0.02	-0.04
Debt / FCF Ratio	-0.08	-0.03	-0.02	-0.03	-0.03	-0.11
Quick Ratio	2.27	2.39	2.22	4.13	3.17	1.10
Current Ratio	2.34	2.43	2.28	4.29	3.27	1.25
Interest Coverage	-816.53	-59872.51	-482.53	-507.41	-133.98	-250.93
Return on Equity (ROE)	-70.80%	-111.10%	-60.50%	-58.50%	-76.00%	-104.80%
Return on Assets (ROA)	-53.80%	-82.00%	-50.00%	-51.10%	-63.60%	-94.20%
Return on Capital (ROIC)	-128.04%	-175.23%	-88.32%	-61.70%	-83.36%	-59.38%
Earnings Yield	-129.48%	-37.18%	-57.34%	-66.88%	-126.12%	-
FCF Yield	-104.67%	-22.49%	-69.71%	-40.27%	-75.87%	-
Buyback Yield / Dilution	-1.77%	-2.21%	-10.84%	-190.15%	-70.69%	-19.49%
Total Shareholder Return	-1.77%	-2.21%	-10.84%	-190.15%	-70.69%	-19.49%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).